Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints

  • Eric Vallabh Minikel
  • , Hien T. Zhao
  • , Jason Le
  • , Jill O'Moore
  • , Rose Pitstick
  • , Samantha Graffam
  • , George A. Carlson
  • , Michael P. Kavanaugh
  • , Jasna Kriz
  • , Jae Beom Kim
  • , Jiyan Ma
  • , Holger Wille
  • , Judd Aiken
  • , Deborah McKenzie
  • , Katsumi Doh-Ura
  • , Matthew Beck
  • , Rhonda O'Keefe
  • , Jacquelyn Stathopoulos
  • , Tyler Caron
  • , Stuart L. Schreiber
    • Jeffrey B. Carroll, Holly B. Kordasiewicz, Deborah E. Cabin, Sonia M. Vallabh

Research output: Contribution to journal › Article › peer-review

88 Scopus citations

Fingerprint

Dive into the research topics of 'Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience

Immunology and Microbiology